IntelliGender release raises abortion fears
By Courier Mail,
Courier Mail
| 05. 10. 2009
A test that claims to determine the sex of an unborn baby only eight weeks into a pregnancy will be available in pharmacies from today.
IntelliGender, the first test of its kind in Australia, claims a 90 per cent accuracy rate in determining whether a baby will be a boy or a girl.
Doctors and the anti-abortion lobby, however, fear the test will be used as a means of sex selection and drive up abortion rates.
The company behind the $95 test, which has been sold in the US since 2006, says it takes 10 minutes and identifies a "confidential element" found in the hormones of a woman pregnant with a girl.
The element is found in very low levels in women pregnant with a boy or not pregnant at all.
Currently, women who want to find out their baby's gender can do so at a routine 18- to 20-week ultrasound to check on the health and development of the child.
Royal Australian and New Zealand College of Obstetricians and Gynaecologists president Dr Ted Weaver said there appeared to be...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
By Grace Won, KQED Forum [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
